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Neurodegeneration in glaucoma results in decline and loss of retinal ganglion cells
(RGCs), and is associated with activation of myeloid cells such as microglia and
macrophages. The chemokine fractalkine (FKN or Cx3cl1) mediates communication from
neurons to myeloid cells. Signaling through its receptor Cx3cr1 has been implicated in
multiple neurodegenerative diseases, but the effects on neuronal pathology are variable.
Since it is unknown how FKN-mediated crosstalk influences RGC degeneration in
glaucoma, we assessed this in a chronic mouse model, DBA/2J. We analyzed a DBA/2J
substrain deficient in Cx3cr1, and compared compartmentalized RGC degeneration and
myeloid cell responses to those in standard DBA/2J mice. We found that loss of FKN
signaling exacerbates axon transport dysfunction, an early event in neurodegeneration,
with a significant increase in RGCs with somal accumulation of the axonal protein
phosphorylated neurofilament, and reduced retinal expression of genes involved in axon
transport, Kif1b, and Atp8a2. There was no change in the loss of Brn3-positive RGCs,
and no difference in the extent of damage to the proximal optic nerve, suggesting
that the loss of fractalkine signaling primarily affects axon transport. Since Cx3cr1 is
specifically expressed in myeloid cells, we assessed changes in retinal microglial number
and activation, changes in gene expression, and the extent of macrophage infiltration. We
found that loss of fractalkine signaling led to innate immune changes within the retina,
including increased infiltration of peripheral macrophages and upregulated nitric oxide
synthase-2 (Nos-2) expression inmyeloid cells, which contributes to the production of NO
and can promote axon transport deficits. In contrast, resident retinal microglia appeared
unchanged either in number, morphology, or expression of the myeloid activation marker
ionized calcium binding adaptor molecule 1 (Iba1). There was also no significant increase
in the proinflammatory gene interleukin 1 beta (Il1β). We conclude that loss of fractalkine
signaling causes a selective worsening of axon transport dysfunction in RGCs, which is
linked to enhanced Nos-2 expression in myeloid cells. Our findings suggest that distinct
mechanismsmay contribute to different aspects of RGC decline in glaucoma, with axonal
transport selectively altered after loss of Cx3cr1 in microglia and/or macrophages.
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INTRODUCTION
The myeloid innate immune system has long been of interest
in the field of neurodegeneration, not only as a responder
to neuronal stress and damage but also as a driver of
neurodegeneration (Ilieva et al., 2009; Czeh et al., 2011). This
is also the case for diverse neurodegenerative ocular diseases,
including glaucoma (Karlstetter et al., 2015). In glaucoma,
retinal ganglion cells (RGCs) progressively degenerate, with the
different neuronal compartments (soma, axon, dendrites, and
synapses) declining at different times and potentially by different
mechanisms (Libby et al., 2005a; Whitmore et al., 2005; Conforti
et al., 2007; Howell et al., 2007; Calkins, 2012; Fernandes et al.,
2014). In addition, multiple studies in human and experimental
glaucoma suggest a link between the progressive deterioration
of RGCs and alterations of glial cell types (Yuan and Neufeld,
2001; Naskar et al., 2002; Neufeld and Liu, 2003; Nakazawa et al.,
2006; Inman and Horner, 2007; Bosco et al., 2011, 2015b; Lye-
Barthel et al., 2013; Chong and Martin, 2015). Microglia are the
resident innate immune cells of the central nervous system, and
in both glaucoma patients and in animal models of glaucoma,
they display increased reactivity and cluster at the optic nerve
head, which is a site of early damage (Bosco et al., 2011; Yuan
and Neufeld, 2001; Roh et al., 2012; Soto and Howell, 2014).
It has also been demonstrated that peripheral macrophages
infiltrate the retina in animal models of glaucoma (Howell
et al., 2012) suggesting that different myeloid cell types may
participate in glaucoma progression. However, it remains unclear
how microglia and macrophages affect RGC compartmentalized
degeneration in glaucoma.
In order to address the role of myeloid cells in
neurodegeneration, many studies have manipulated the
fractalkine (FKN) signaling system, which serves as a major
neuron-to-myeloid cell communication system (Hoarau et al.,
2011; Limatola and Ransohoff, 2014). The FKN receptor, Cx3cr1,
is specifically expressed by cells of the myeloid lineage, including
microglia, while the FKN ligand, Cx3cl1, is highly expressed
by neurons (Jung et al., 2000; Cook et al., 2001). Multiple
studies have suggested that Cx3cl1/Cx3cr1 signaling functions
to constrain microglial activation, and thus limit potentially
neurotoxic effects (Cardona et al., 2006; Limatola and Ransohoff,
2014). However, it is now appreciated that diverse myeloid
functions are regulated by FKN signaling, including cytokine
secretion, microglial activation, phagocytosis, process dynamics,
migration, survival of subsets of circulating monocytes, and
infiltration of macrophages positive for chemokine C-C motif
receptor 2 (Ccr2) (Cardona et al., 2006; Lee et al., 2008;
Landsman et al., 2009; Liang et al., 2009; Sennlaub et al., 2013).
Abbreviations: RGC, retinal ganglion cell; pNF, phosphorylated neurofilament;
RT-PCR, reverse transcriptase polymerase chain reaction; Gapdh, glyceraldehyde
3-phosphate dehydrogenase; FACS, fluorescence-activated cell sorting; PBS,
phosphate buffered saline; PPD, paraphenylenediamine; Iba1, ionized calcium
binding adaptor molecule 1; Nos-2, nitric oxide synthase 2; NO, nitric oxide; Il1β,
interleukin 1 beta; Mfge8, milk fat globule-EGF factor 8 protein; Dlk, dual leucine
kinase; Ccl2, chemokine C-C motif ligand 2; Ccr2, chemokine C-C motif receptor
2; Cx3cl1, fractalkine; Cx3cr1, fractalkine receptor; GFP, green fluorescent protein;
Cx3cr1gfp/gfp, Cx3cr1 -gfp knockin.
Given these complex roles, it is not surprising that loss of
FKN signaling has diverse and sometimes contradictory effects
on neurodegeneration (Wolf et al., 2013). For example, loss
of FKN signaling simultaneously reduces amyloid-β burden
and increases tau pathology in the same mouse model of
Alzheimer’s disease (Lee et al., 2014). These findings suggest
that myeloid cells may differentially influence distinct aspects
of neurodegeneration. However, the role of these cells is still
incompletely understood, particularly for progressive age-related
neurodegeneration including glaucoma.
The DBA/2J mouse models key aspects of neurodegeneration
in human glaucoma because the decline of RGCs occurs in an
age-related and asynchronous manner with variable onset (John
et al., 1998; Anderson et al., 2002; Jakobs et al., 2005; Libby et al.,
2005a). Multiple quantitative readouts have been established
demonstrating progressive compartmental degeneration of
RGCs in the DBA/2J retina and optic nerve. These include early
downregulation of RGC genes such as the transcription factor
Brn3b, accumulation of axonal proteins such as phosphorylated
neurofilament (pNF) within RGC somata as transport declines,
and loss of axons with subsequent gliosis in the optic nerve (Libby
et al., 2005a,b; Schlamp et al., 2006; Buckingham et al., 2008; Soto
et al., 2008; Dengler-Crish et al., 2014; Bosco et al., 2015b; Cooper
et al., 2016). Furthermore, alterations of both resident microglia
and infiltrating macrophages have been documented in this
model, although the impact of these cells on RGC degeneration
remains poorly understood (Mo et al., 2003; Anderson et al.,
2008; Bosco et al., 2011, 2015b; Howell et al., 2012).
To address this, we sought to manipulate
microglia/macrophage function and assess the effects on
RGC neurodegeneration. We therefore analyzed the retinas
of 10–11 month-old DBA/2J mice lacking the FKN receptor,
Cx3cr1, for neuroprotective, or deleterious effects in the retina
and optic nerve. Thus, we measured the density of Brn3-positive
nuclei and somal pNF-positive cells across whole retinas, and
analyzed the respective optic nerves for the extent of glial
coverage as a proxy for axon dropout. In these same samples, we
assessed changes in myeloid cells in the retina by quantifying cell
densities of myeloid cell populations and assessing microglial
activation by Iba1 immunostaining. We then performed flow
cytometry to assess infiltration of CCR2+ macrophages and
measured gene expression changes by qRT-PCR. We show that
loss of fractalkine signaling in myeloid cells increases infiltration
of Ccr2+ macrophages into the DBA/2J retina, selectively
worsens axon transport dysfunction in RGCs, and is associated
with selective changes in the expression of genes related to axon
transport deficits.
MATERIALS AND METHODS
Mice
Cx3cr1gfp/gfp DBA/2J mice were generated by breeding existing
Cx3cr1gfp/+ DBA/2J mice to homozygosity (Bosco et al., 2015b).
DBA/2J mice were obtained from Jackson Labs, bred in-house,
and were refreshed with new breeders every 3–4 generations.
Both male and female mice were used for analysis (n = 36
Cx3cr1gfp/gfp DBA/2J mice, 21 male, 15 female; n = 31 DBA/2J
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mice, 15 male, 16 female). Mice from both strains were aged
to 10–11 months, when a majority of DBA/2J eyes typically
show clear glaucoma pathology (Libby et al., 2005a). Although
animals of mixed gender were used, we have excluded gender as a
contributing factor, since our findings were confirmed by analysis
of data from male animals alone (data not shown). Experiments
and mouse care were performed in compliance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research, and with the guidelines of the University of Utah
Institutional Animal Care and Use Committee.
Tissue Collection
Perfusion and dissection of retinal tissue and optic nerves
for both immunohistochemistry and RNA collection were
performed as previously described (Bosco et al., 2011). Briefly,
retinas were dissected fresh under RNAase-free conditions
for RNA isolation, or dissected from transcardially perfused
mice as whole mounts, which were stored in chilled 0.1 M
phosphate-buffered saline (PBS) overnight at 4◦C and utilized
the next day for immunohistochemistry. Also, retinal eyecups
were cryoprotected, cast in gelatin blocks that were stored
at −80◦C, and cryosectioned radially at 16 µm thickness for
immunohistochemistry. Optic nerves were postfixed, embedded
in resin and prepared as 1–2 µm-thick cross-sections for
toluidine blue and paraphenylenediamine (PPD) staining (Bosco
et al., 2015b).
Immunohistochemistry
Triple immunofluorescence staining was performed using
established protocols and antibodies, as previously described in
detail (Bosco et al., 2011). Retinal whole mount and cryosections
were incubated with primary antibodies for 3 days at 4◦C and
incubated with secondary antibodies for 2 h. Primary antibodies
used in this study included: goat anti-Brn3 (Santa Cruz sc-
6026 at 1:50), mouse anti-phosphorylated neurofilament (pNF;
including NFM and NFH; Dako M0762 at 1:100), rabbit anti-
Iba1 (Wako at 1:1000), rat anti-CCR2 APC conjugated (R&D
Systems FAB5538A at 1:10), and rabbit anti-cleaved caspase
3 (BD Biosciences BDB559565 at 1:500). pNF staining co-
labeled with rabbit polyclonal neurofilament heavy antibody
(Biolegend 801703) and in separate experiments was absent when
primary antibody was omitted. All Alexa Fluor-conjugated (488,
568, or 647 nm) donkey secondary antibodies were used at
1:400 (Invitrogen); Alexa-Fluor 594-conjugated donkey anti rat
secondary was used at 1:200 (Jackson ImmunoResearch Lab).
In situ Hybridization
Antisense and sense 3′UTR Dig labeled probes were generated
from pCMV-SPORT6 Cx3cl1 (MGC 5859) obtained from
ATCC. Probes were synthesized and hybridized using standard
procedures as in Soto et al. (2008) without the use of proteinase
K. Briefly, mice were perfused, eyes cast in gelatin, and 16
um radial cryosections were generated as described in their
respective sections. Bound probes were detected using 1:300
Anti-Dig AP antibody (Sigma 11093274910) overnight at 4◦C
with 30 min color development using NBT/BCIP tablets (Sigma
11697471001).
Microscopy
All retinal samples were imaged on an inverted confocal
microscope (Nikon A1 with NIS-Elements software 4.2) using a
20x objective and resonance scanning (Bosco et al., 2012). Entire
retinas were imaged using a multipoint acquisition macro of the
software, collecting 25 × 25 fields at 60x magnification (0.41
µm/pixel), each spanning 30–40 µm of the retinal inner surface
through a step size of 0.8 µm. Maximum intensity projections
of stitched, high-resolution images were then generated for each
retina, and all images were identically and minimally adjusted
for brightness and contrast for analysis. Optic nerves were
imaged on a compound BX51 Olympus light microscope using
a 60X objective and analyzed using cellSens software as 36 high-
resolution multipoint images (Bosco et al., 2015b).
Quantification of Brn3+ Nuclei
Brn3+ nuclei, corresponding to RGCs expressing Brn3a and
Brn3b (Bosco et al., 2011), were sampled within the central 1.77
µm2 of the retina by dividing a circle centered on the optic disk
into eight parts (2 dorsal, 2 ventral, 2 nasal, and 2 temporal). A
250 × 250 µm box was placed in each of these areas with blood
vessels used as landmarks. RGC degeneration in the DBA/2J
model is sectorial (Jakobs et al., 2005; Howell et al., 2007), so to
avoid bias, when two sectors were visible within an eighth of the
retina being analyzed, two boxes were placed one in each sector.
The total number of Brn3+ nuclei were tallied and normalized to
the area sampled (∼0.06 mm2 per box). To be counted, nuclei
had to be spherical/elliptical in shape and >1.5x the intensity
of the background. Debris was uniformly more intense than
Brn3+ nuclei and was excluded from the quantification. Retinas
were then sorted from highest to lowest Brn3+ nuclei density.
The distribution of densities of Brn3+ nuclei was not normally
distributed therefore aWilcoxon rank sum test was used to assess
significance.
Quantification of Somal pNF+ RGCs
Cell somas with accumulated phosphorylated neurofilament
(pNF) were quantified in the central 1.77 µm2 of the retina, as
described for Brn3. RGC somata were identified based on shape
(reflecting either somatic or somato-dendritic accumulation),
size being >10 µm in diameter and fluorescence intensity being
>1.5x the background. Somal pNF positive RGCs were verified to
be negative for Iba1. RGCs positive for both Brn3 and somal pNF
or just somal pNF were quantified. Retinas were then sorted from
lowest to highest somal pNF+ RGC density. The distribution of
densities of pNF+ cells was not normally distributed therefore a
Wilcoxon rank sum test was used to assess significance.
Quantification of Iba1+ Cells
Three categories of Iba1+ cell were determined based on
morphology: branched Iba1+ cells with a small cell soma
and more than two branches, perivascular Iba1+ cells having
two main branches at polar opposite sides of the cell, and
amoeboid Iba1+ cells having no branches. Branched Iba1+ and
perivascular Iba1+ cells were quantified in the central 1.77 um2
of the retina, as described for Brn3, excluding the optic disk.
Amoeboid Iba1+ cells, being fewer in number, were quantified in
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the entire retina, excluding the optic disk and the lumen of blood
vessels. Retinas were then sorted from lowest to highest density
of the respective Iba1+cell morphological class. The distribution
of densities of perivascular and amoeboid Iba1+ cells was not
normally distributed and was analyzed by Wilcoxon rank sum
test. The distribution of branched Iba1+ cells was normally
distributed and was analyzed by Student’s t-test.
Optic Nerve Histopathology
Optic nerve cross-sections from the myelinated portion of the
nerve, 1–1.5 mm proximal to the lamina, were embedded and 1
µm sections were cut on an ultramicrotome with a glass knife
then transferred to slides. Sections were stained with PPD (Libby
et al., 2005a) for 28 min using a modified protocol as previously
described (Bosco et al., 2015a,b), and mounted under coverslips
with Permount (Fisher).
Quantification of Non-axonal Area in the
Proximal Optic Nerve
The relative area devoid of axons or dystrophic axons
in individual optic nerve cross-sections was measured by
segmentation of glial cells and/or glial scar and extracellular
matrix from 8-bit stitched RGB images of PPD stained nerves,
as previously described (Bosco et al., 2015a,b, 2016). The green
channel of the RGB image provided the greatest contrast to
segment glial area from non-glial elements including axons
and blood vessels. Briefly, the green channel of RGB images
minimally adjusted for contrast (0–10 on a scale to 0–100) and
sharpness (Gauss Laplace between 1.0 and 1.1 on a scale of 0–
2), were thresholded to generate a binary mask encompassing the
total cross-sectional area of the optic nerve, excluding meninges
and blood vessels. The axon-free nerve relative area was then
calculated by determining the percent of the total optic nerve
that is covered by non-axonal cells or matrix. Optic nerves
were then sorted from lowest to highest percent non-axonal
area. The distribution of percent optic nerve covered by non-
axonal elements was not normally distributed and was analyzed
by Wilcoxon rank sum test. To verify this analysis, a subset
of 24 DBA/2J and 24 Cx3cr1gfp/gfp DBA/2J PPD-stained optic
nerves were blindly scored using a three-category system as mild,
moderate, or severe, as in Libby et al. (2005a). Mild degeneration
consisted of nerves with no or very little loss of axons and no
gliosis. Moderate degeneration consisted of little to no gliosis but
a clear presence of dystrophic axons, while a majority remained
healthy. Severe degeneration consisted of nerves with clear and
frequently extensive gliosis and a majority of dystrophic axons
with clear and significant loss of axons overall. No significant
difference was found between the genotypes with a chi-squared
value of 0.93.
Fluorescence-Activated Cell Sorting
(FACS) and Flow Cytometry
Four female DBA/2J or three Cx3cr1gfp/gfp DBA/2J female mice
at 12 months of age were perfused with saline. Retinas were
dissociated in PBS, 50 mM HEPES, 0.05 mg/ml DNaseI (Sigma
D4513), 0.025 mg/ml Liberase (Sigma 5401119001) for 35 min
with intermediate trituration. Cells were passed through a 70
µm nylon cell strainer, washed with staining buffer (1X PBS, 2%
BSA, 0.1% sodium azide, 0.05% EDTA), and red blood cells were
lysed (eBioscience 00-4333-57). Cell counts were determined
using a hemocytometer and Fc block (BD Biosciences 553142)
was added 2 µl per 106 cells. Antibodies were applied for 30
min on ice (BV421-CD45 563890, PE-CD11b 553311, APC-Ccr2
FAB5538A100). Cells were washed, pelleted, and resuspended
in 500 µl staining buffer. FACS was performed using a BD
FACSAria cell sorter. CD11b+, CD45+, CCR2 ± were sorted
directly into RLT buffer (Qiagen 79216) and stored at −20◦C.
RNA from sorted cells was purified using an RNeasy Plus Micro
kit (Qiagen 74034) and reverse transcribed using SuperScript
IV Reverse transcriptase (Invitrogen 18090019). 832,000–937,000
events were collected for flow analysis using BD FACSDiva
software. CCR2+ populations were analyzed gating on live
CD11b+ CD45+ cells. Unstained retinas and spleens stained for
CD11b, CD45 and CCR2 from the same animals were used as
negative and positive controls, respectively.
Quantitative RT-PCR
Sample preparation, cDNA synthesis, and quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR) were
performed as previously described (Bosco et al., 2011). Briefly,
whole retinas were aspirated through a 22-gage needle and RNA
was isolated using a Qiagen RNeasy micro kit according to
manufacturer’s instructions. The mRNA quality was determined
on an Agilent Bioanalyzer and samples with RNA integrity
numbers <8 were discarded. First strand cDNA was synthesized
using an Invitrogen Superscript III First Strand cDNA synthesis
kit according tomanufacturer’s recommendations, and quantities
determined on a Nano-drop spectrophotometer. qRT-PCR was
performed on an Applied Biosystems 7900 HT instrument
with QuantStudio 12K Flex software using an Invitrogen
Platinum Sybr Green qPCR supermix-UDG kit according to
manufacturer’s instructions. For analysis of whole retina samples
(all genes except Nos-2 and interleukin 1β (Il1β)), a standard
curve was generated based on five serial one-half dilutions of
pooled cDNAs from a large number of 1–12-month DBA/2J
retinas, and genes were analyzed in the linear range based on
these curves. For Nos-2 and Il1β, we used the 11Ct method to
calculate the relative fold change in gene expression (Livak and
Schmittgen, 2001), and statistical analysis was performed using
Student’s t-test on all genes. Analyzed genes were normalized
to glyceraldehyde 3-phosphate dehydrogenase (Gapdh). For
statistical analysis, genes that did not amplify were set to 40
cycles, which is the limit of detection.
Primers used 5′–3′:
GapdhF: TGCACCACCAACTGCTTAGC
GapdhR: GGCATGGACTGTGGTCATGAG
Iba1F: CCTGATTGGAGGTGGATGTCA
Iba1R: GGCTCACGACTGTTTCTTTTTTCC
Kif1bF: TTATTGATACATCCATGGGGTC
Kif1bR: TCTCCTGAATACTGGTCACA
Atp8a2F: CTTTGTGTTTTGTTTTCCCCGC
Atp8a2R: CGCTGTACTTGGCCGTACTGA
Mfge8F: GGATAATCAGGGCAAGATCA
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Mfge8R: TAGGACGCCACATACTGGAT
Ccr2F: AAGGAGCCATACCTGTAAATGC
Ccr2R: ATGCCGTGGATGAACTGAGG
Ccl2F: CACTCACCTGCTGCTACTCA
Ccl2R: GCTTGGTGACAAAAACTACAGC
Nos-2F: TCTTGGAGCGAGTTGTGGATT
Nos-2R: CAGCCTCTTGTCTTTGACCCA
Il1βF: ACATCAGCACCTCACAAGCAGAG
Il1βR: TGGGGAAGGCATTAGAAACAGTC
Intraocular Pressure (IOP)
IOP was determined as previously described (Bosco et al., 2011)
with the exception of Isoflurane being used as anesthesia instead
of Avertin. Briefly, mice were anesthetized using Isoflurane (2%
delivered in 2 L/min oxygen) and IOP was measured using
a Tonolab (Colonial Medical Supply) positioned to strike the
center of the eye. Twelve measurements were collected per eye
before noon, the top and bottom measurement discarded, and
the remainder averaged with a SEM <0.7. By assessing mice at
3, 6, and 9 mo of age (n = 24, 14, and 28 eyes respectively),
we confirmed that in Cx3cr1gfp/gfp DBA/2J mice there was no
enhancement of the existent elevation in IOP documented in
DBA/2J mice (Libby et al., 2005a) and iris atrophy was present
(data not shown).
Statistics
Statistical analyses for each method are described in their
respective sections. Normality of the data was examined both
by histogram distribution and by percentage of data falling 1
and 2 standard deviations away from the mean. When data were
not normally distributed, we created a macro in Excel to run
a Wilcoxon rank sum test to determine whether the rank of
the population means were significantly different. Kolmogorov-
Smirnov test was performed by utilizing an online tool developed
at St. John’s University (retrieved from http://www.physics.
csbsju.edu/stats/KS-test.html).
RESULTS
Loss of Cx3cr1 Exacerbates RGC Axon
Dysfunction in the DBA/2J Retina
Since the FKN ligand is enriched in the ganglion cell layer of
the retina in both humans and mice (Silverman et al., 2003;
Zieger et al., 2014) including RGCs in the DBA/2J (Supplemental
Figure 1), we reasoned that loss of FKN signaling may influence
key aspects of RGC decline in glaucoma. Deficits in axonal
transport progressively affect RGC axon and somal integrity in
glaucoma (Soto et al., 2008; Crish et al., 2010; Dengler-Crish
et al., 2014). One marker of disrupted axonal transport is the
build-up of phosphorylated neurofilament (pNF; medium and
heavy) proteins within the proximal axon segment, cell body, and
dendrites of RGCs (Soto et al., 2008). Within the central retina
of DBA/2J and Cx3cr1gfp/gfp DBA/2J mice at 10–11 months of
age we found regions with both low and high numbers of somal
pNF+ RGCs (Figures 1A–C), consistent with the variable levels
of pathology in the DBA/2J model. We observed an overall
increase in the density of somal pNF+ RGCs in Cx3cr1gfp/gfp
DBA/2J vs. DBA/2J retinas (Figure 1D), with a significant shift
in the distribution toward higher mean densities of somal pNF+
RGCs for Cx3cr1gfp/gfp DBA/2J mice than in standard DBA/2J
retinas (p < 0.05 by Kolmogorov-Smirnov test). This resulted in
a significantly increased populationmean density of somal pNF+
RGCs in Cx3cr1gfp/gfp DBA/2J compared to the DBA/2J retinas
(10.51 vs. 6.46 cells/mm2 respectively, Figure 1D; p < 0.05 by
Wilcoxon rank sum test).
Since somal accumulation of pNF suggests deficits in axonal
transport, we isolated whole retina mRNA and performed
quantitative RT-PCR to determine whether there is altered
expression of genes involved in axon transport. Previous work
has shown reduced expression of the anterograde transport
motor Kif1b within sectors of DBA/2J retinas depleted of
Fluorogold positive RGCs (Panagis et al., 2010). Compared to
DBA/2J, we found that expression of Kif1b was significantly
reduced in Cx3cr1gfp/gfp DBA/2J retinas (25% reduction; n
= 9 retinas Cx3cr1gfp/gfp DBA/2J, n = 8 DBA/2J; p < 0.05,
Student’s t-test, Figure 1E). Loss of the phosphatidyl-serine
flippase, Atp8a2, also disrupts axonal transport with an increase
in RGCs with somal pNF (Zhu et al., 2012). Expression of Atp8a2
by qRT-PCR was also significantly reduced in Cx3cr1gfp/gfp
DBA/2J vs. DBA/2J retinas (15% reduction; n = 9 retinas
Cx3cr1gfp/gfp DBA/2J, n = 8 DBA/2J; p < 0.05 Student’s t-test,
Figure 1E). Thus, we findmultiple lines of evidence for increased
axon transport dysfunction in the DBA/2J retina with loss of
fractalkine signaling.
Loss of Cx3cr1 in DBA/2J Mice Increases
the Number of Early Declining RGCs
Since loss of fractalkine signaling resulted in increased numbers
of somal pNF+ RGCs, we reasoned that this could be due
to increased numbers of affected RGCs, impaired clearance
of degenerating RGCs, or both. To determine whether the
increase in pNF RGCs was due to impaired clearance we
identified RGCs in earlier and later stages of degeneration. Early
declining RGCs downregulate the expression of characteristic
genes such as members of the Brn3 transcription factor
family in response to damage (Schlamp et al., 2001; Huang
et al., 2006; Buckingham et al., 2008; Soto et al., 2008).
In the DBA/2J retina Brn3 downregulation precedes the
clearance of the RGC soma by several weeks (Soto et al.,
2008). We quantified subsets of RGCs with somal buildup
of pNF with or without nuclear Brn3 expression in DBA/2J
and Cx3cr1gfp/gfp DBA/2J retinas. In both genotypes we
identified three populations of RGCs at 10–11 months: healthy
RGCs that express Brn3 and lack somal pNF (Brn3+/pNF-;
Figure 2A); early declining RGCs that express Brn3 but
accumulate somal/somatodendritic pNF (Brn3+/pNF+;
Figure 2B); and RGCs in later stages of degeneration that
lose Brn3 expression and retain somal/somatodendritic pNF
(Brn3-/pNF+; Figure 2C) before ultimately being eliminated.
Quantification of the relative cell density for these three
subsets of RGCs revealed a higher proportion of Cx3cr1gfp/gfp
DBA/2J retinas that had Brn3+/pNF+ RGCs compared to
age-matched DBA/2J mice and a significant increase in the
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FIGURE 1 | More RGCs have somal accumulation of pNF and axonal transport genes are downregulated with loss of fractalkine signaling. (A) Confocal
image of a Cx3cr1gfp/gfp DBA/2J retinal flat mount immunostained for phosphorylated-neurofilament (pNF), depicting the sampled central retinal area (1.77 mm2 ).
This retina has few somal pNF+ RGCs and smooth, fasciculated axons. Yellow boxes indicate cells that show pNF accumulated within the cell soma. (B) Higher
magnification view of an area in A (red box), depicting a cell with accumulated somal pNF. (C) Higher magnification of the central retinal area from a different
Cx3cr1gfp/gfp DBA/2J retina (same dimensions as in B) with abundant somal pNF+ RGCs as well as beaded and defasciculated axons. (D) Distribution of the
number of cells with somal pNF within the central retina in DBA/2J (blue; n = 31 retinas) and Cx3cr1gfp/gfp DBA/2J (red; n = 36 retinas) sorted in ascending order.
There are significantly more somal pNF+ cells in Cx3cr1gfp/gfp retinas (*p < 0.05; Wilcoxon ranked sum test). Solid horizontal line indicates the population mean,
dashed lines indicate 1 standard deviation above and below the mean. Error bars represent the SEM. (E) There is significantly less expression of axonal transport
genes Kif1b and Atp8a2 in Cx3cr1gfp/gfp DBA/2J whole retina cDNA (25% and 15% less expression respectively, *p < 0.05; Student’s t-test; error bars represent the
SEM, n = 8 DBA/2J retinas and 9 Cx3cr1gfp/gfp DBA/2J retinas). Scale bars: 500 µm (A); 50 µm (B,C).
mean density of Brn3+/pNF+ RGCs (1.47 vs. 1.03 cells/mm2
respectively, Figure 2D; p < 0.05 by Wilcoxon rank sum test),
demonstrating an increase in early declining RGCs in the absence
of fractalkine signaling. We also measured a significant increase
in the mean number of Brn3-/pNF+ RGCs in late stages of
degeneration, consistent with the overall increase in pNF+ RGCs
(9.02 vs. 5.43 cells/mm2 respectively, Figure 2E; p < 0.05 by
Wilcoxon rank sum test). Since there was not a selective increase
in Brn3-/pNF+ RGCs, we conclude that the increased density
of RGCs with somal pNF buildup is not simply a failure to
clear RGCs in late stages of decline in Cx3cr1gfp/gfp DBA/2J
retinas.
To further assess possible changes in clearance and cell
death, we performed immunostaining for cleaved caspase 3,
and found that none of the pNF+ cells were positive (0
out of 40 somal pNF+ RGCs, n = 2 retinas; Supplemental
Figure 2). In addition, we observed that the nuclei of RGCs
with somal pNF accumulation were not pyknotic (Supplemental
Figure 3) suggesting they are not yet undergoing apoptosis. Since
fractalkine has been shown to induce expression of the opsonin
milk fat globule-EGF factor 8 (Mfge8), which stimulates myeloid
cells to clear apoptotic neurons (Fuller and Van Eldik, 2008)
we assessed levels of Mfge8 mRNA. However, we found no
significant difference in Cx3cr1gfp/gfp DBA/2J (n= 3) vs. DBA/2J
(n = 3) retinas (p > 0.05, Student’s t-test; data not shown).
Together, these findings suggest that loss of fractalkine signaling
is amplifying the generation of dystrophic RGCs rather than
impairing their clearance.
Loss of Cx3cr1 in the DBA/2J Mouse Does
Not Alter Brn3-Positive RGC Numbers
To determine if loss of Cx3cr1 affected other retinal readouts
of RGC compartmentalized degeneration we assessed whether
loss of fractalkine signaling altered the density of cells expressing
Brn3 within the ganglion cell layer (Figure 3A). We quantified
the density of Brn3+ nuclei in eight sectors for each retina
(Figure 3A), and found that regardless of genotype, there
were regions with high and low numbers of Brn3+ nuclei
(Figures 3B–E), consistent with sectorial downregulation of Brn3
expression in both DBA/2J and Cx3cr1gfp/gfp DBA/2J retinas. We
then calculated average densities of Brn3+ nuclei for each retina
(Figure 3F). There were similar maximum densities of Brn3+
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FIGURE 2 | Loss of fractalkine signaling results in increased numbers of RGCs in both early and late stages of decline. (A) Confocal image of retinal flat
mount showing Brn3+ nuclei that lack accumulation of somal pNF. (B,C) Confocal image of cells with somal accumulation of pNF, and either expression (B) or
absence (C) of Brn3. Orthogonal views in the x-y (bottom) and y-z (side) planes are shown. (D,E) Distribution of the density of cells that are Brn3+/somal pNF+ (D) or
Brn3-/somal pNF+ (E) within the central retina in DBA/2J (blue n = 31 retinas) and Cx3cr1gfp/gfp DBA/2J (red n = 36 retinas) mice, sorted in ascending order.
Cx3cr1gfp/gfp DBA/2J retinas contain significantly more Brn3+/somal pNF+ cells (D, * p < 0.05; Wilcoxon ranked sum test) and Brn3-/somal pNF+ cells (E, *p <
0.05; Wilcoxon ranked sum test) than DBA/2J retinas. Solid horizontal line indicates the population mean, dashed lines indicate 1 standard deviation above and below
the mean. Error bars represent the SEM. Scale bars: 10 µm.
nuclei in each genotype (2400/mm2 in DBA/2J and 2300/mm2
in Cx3cr1gfp/gfp DBA/2J Figure 3F), and similar distribution
of retinas with varying levels of Brn3 depletion (Figure 3F),
consistent with the range of disease severity typically observed
in the DBA/2J model (Buckingham et al., 2008). Likewise, the
population mean densities of Brn3+ nuclei for each genotype
were not significantly different (867 and 846 cells per mm2
respectively, Figure 3F; p > 0.05 Wilcoxon rank sum test).
To rule out sampling artifacts, we counted all Brn3+ nuclei
within the central retina (1.77 mm2) for a subset of retinas
(n = 6 DBA/2J and 7 Cx3cr1gfp/gfp DBA/2J with similar ranges
of pathology), and obtained similar results (data not shown).
Therefore, we conclude that at this timepoint, loss of fractalkine
signaling did not affect the characteristic downregulation of
Brn3 expression in RGCs that occurs in the DBA/2J retina
with age.
Loss Of Cx3cr1 in DBA/2J Mice Does Not
Exacerbate Optic Nerve Degeneration
RGC degeneration in the DBA/2J model is well characterized
within the optic nerve to include a progressive loss of RGC axons
and a subsequent replacement by glia and extracellular matrix
(John et al., 1998; Libby et al., 2005a; Schlamp et al., 2006; Lye-
Barthel et al., 2013; Bosco et al., 2015a,b, 2016; Cooper et al.,
2016). To determine if the potential impact on axonal transport
by loss of Cx3cr1 affected optic nerve degeneration, we estimated
the relative coverage of non-axonal area using segmentation of
glia and extracellular matrix in nerve cross-sections (Bosco et al.,
2015a,b, 2016). For both the DBA/2J and Cx3cr1gfp/gfp DBA/2J
genotypes at 10–11 months, we observed a similar distribution
of nerves with non-axonal area ranging from 10 to above 95%
in individual nerves (Figures 4A–E). We did not observe a
statistically significant difference in the mean non-axonal area
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FIGURE 3 | The density of Brn3+ nuclei does not change with loss of fractalkine signaling. (A) Confocal image of a representative Cx3cr1gfp/gfp DBA/2J
retinal flat mount showing the Brn3 immunofluorescence in the central retinal area (1.77 mm2 ). Red boxes depict examples of 0.06 mm2 fields sampled across 8
sectors. (B–E) Higher magnification images of 0.06 mm2 fields (250 × 250µm) in retinas from DBA/2J (B,D) or Cx3cr1gfp/gfp DBA/2J (C,E), representative of high
(B,C), and low (D,E) Brn3+ nucleus density. (F) Distribution of Brn3+ nuclei densities per retina in DBA/2J (blue; n = 31 retinas) and Cx3cr1gfp/gfp DBA/2J (red; n =
36 retinas), sorted from high to low density. Solid horizontal lines indicate population means, dashed lines indicate 1 standard deviation above and below the mean.
Error bars represent the SEM (n.s.: p > 0.05; Wilcoxon ranked sum test). Asterisk indicates optic nerve head. Scale bars: 500 µm (A); 50 µm (B–E).
for Cx3cr1gfp/gfp DBA/2J optic nerves as compared to DBA/2J
(42 and 39% respectively; Figure 4E; p > 0.05 by Wilcoxon rank
sum test). To confirm these findings, we used a qualitative scoring
method (Libby et al., 2005a) on a subset of 24 nerves of each
genotype, and did not find a significant difference in optic nerve
degeneration between the genotypes (Chi-squared value of 0.93;
data not shown). Therefore, we conclude that loss of fractalkine
signaling did not alter proximal optic nerve degeneration on the
DBA/2J background at this age.
Macrophage Infiltration Is Increased in
Cx3cr1gfp/Gfp DBA/2J Retinas
Given that fractalkine signaling regulates many myeloid cell
responses, including microglial activation, as well as peripheral
monocyte recruitment and distribution (Cardona et al., 2006;
Sennlaub et al., 2013; Wolf et al., 2013; Limatola and Ransohoff,
2014), we examined how loss of the fractalkine receptor affected
myeloid cells in terms of morphology, number, distribution, and
levels of the activation-associated gene, Iba1 in 10–11 month-
old Cx3cr1gfp/gfp DBA/2J vs. DBA/2J retinas. We observed
three distinct morphological subtypes of Iba1+ cells within the
retina: cells with a small soma and many processes (“branched”),
cells with two main processes on polar opposite sides typically
outlining blood vessels (“perivascular”), and spherical cells
with no processes (“amoeboid”) (Figures 5A–C). We presume
these Iba1+ cell subtypes to respectively represent resident
parenchymal microglia, perivascular macrophages, and either
infiltrating macrophages or highly activated resident microglia.
We found no change in the density of branched Iba1+ cells
(Figure 5E; p > 0.05 by Student’s t-test) between Cx3cr1gfp/gfp
DBA/2J retinas compared to DBA/2J retinas, suggesting no
change in the resident microglia population. There was a trend
toward an increase in the mean density of perivascular cells in
Cx3cr1gfp/gfp DBA/2J retinas (Figure 5F, p < 0.1 by Wilcoxon
rank sum test), and a significant 1.7-fold increase in the mean
density of amoeboid Iba1+ cells (Figure 5G, p < 0.05 by
Wilcoxon rank sum test).
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FIGURE 4 | There is no difference in the amount of gliosis and scarring in the optic nerve with loss of fractalkine signaling. (A) Low magnification
micrograph of a healthy optic nerve cross section with low gliosis and few dystrophic axonal profiles used for subsequent image analysis. (B) The same nerve in (A)
after threshold-based segmentation of non-axonal area, including glia, and extracellular matrix but excluding blood vessels (binary mask in green). (C) Low
magnification micrograph of a diseased optic nerve cross section with high gliosis and many dystrophic axonal profiles used for subsequent image analysis. (D) The
same nerve in (C) after segmentation of the non-axonal areas, including gliotic and scar areas (binary mask in green). (E) Distribution of the non-axonal area
percentages per optic nerve in DBA/2J (blue, n = 31) and Cx3cr1gfp/gfp null DBA/2J (red n = 36) sorted in ascending order. There is no significant difference between
the genotypes (n.s. p > 0.05; Wilcoxon ranked sum test). Horizontal lines indicate the population mean, dashed lines indicate 1 standard deviation above and below
the mean. Error bars represent the SEM. Scale bars: 50 µm.
To determine whether the amoeboid Iba1+ cells were
infiltrating macrophages, we first confirmed their exclusive
localization to the nerve fiber layer by volumetric view of
confocal image stacks (Figure 6A), a distribution previously
reported for infiltrating macrophages in retinal injury paradigms
(Garcia-Valenzuela and Sharma, 1999) and for macrophages
that patrol the vitreous body (Vagaja et al., 2012). Furthermore,
to positively identify these amoeboid Iba1+ cells as peripheral
monocytes and not as microglia, we immunostained retinas
for the peripheral macrophage marker CCR2 (Saederup et al.,
2010). We determined that the amoeboid shaped Iba1+ cells
stained positive for CCR2 in five whole mount DBA/2J retinas
(Figure 6B) and in two whole mount Cx3cr1gfp/gfp DBA/2J
retinas (Figure 6C), confirming their identity as peripherally
derived macrophages. Consistent with this, qRT-PCR analysis
showed a 3-fold increase in levels of Ccr2 expression in
Cx3cr1gfp/gfp DBA/2J retinas (n = 5) vs. DBA/2J retinas (n =
5; p < 0.05; Student’s t-test, Figure 6D). There was a concurrent
2-fold increase in levels of the ligand Ccl2 which can promote
macrophage infiltration (n = 5 each; p < 0.05; Student’s t-test,
Figure 6D).
To selectively sort for myeloid cell types present in the DBA/2J
retina, and further confirm an increase in peripherally-derived
macrophages in the absence of fractalkine signaling, we
performed flow cytometry analysis on Cx3cr1gfp/gfp DBA/2J
(n = 6) and DBA/2J (n = 8) retinas, evaluating CD11b+,
CD45+, CCR2 ± cells (Figures 6E–G). CCR2+ cells account
for approximately 15% of the CD11b+ CD45+ double positive
myeloid population in 12 month-old DBA/2J retinas, while
they represent about 33% in age-matched Cx3cr1gfp/gfp DBA/2J
retinas (Figure 6H). Thus, the CCR2+ cells, which represent
peripherally-derived macrophages, are more than doubled in
Cx3cr1gfp/gfp DBA/2J retinas, which is consistent with the
observed increase in amoeboid Iba1+ cells in the retinas lacking
Cx3cr1 (Figure 5G).
Loss of FKN Signaling Results in Selective
Changes in Myeloid Cell Gene Expression
To determine how loss of fractalkine signaling in myeloid
cells might impact pathways involved in RGC degeneration, we
assessed changes in expression of genes associated with myeloid
cell activation between Cx3cr1gfp/gfp DBA/2J and DBA/2J retinas.
qRT-PCR analysis of whole retina RNA detected equal levels of
Iba1 mRNA between the genotypes (n = 5 each, Figure 5D),
suggesting no significant changes in the overall levels of myeloid
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FIGURE 5 | Loss of fractalkine signaling results in greater numbers of amoeboid shaped Iba1+ cells. (A) Low magnification view of an entire retinal flat
mount that was sampled for Iba1+ cells. Blood vessels (traced) were excluded from analysis. (B) Low magnification image of the central retina (1.77 mm2 ) depicting
the area sampled for branched and perivascular shaped Iba1+ cells excluding the optic nerve head (marked by an asterisk and traced by the red circle). (C) Higher
magnification view of the area indicated in A demonstrating the 3 categories of shapes for Iba1+ cells, showing an amoeboid morphology (circle), complex branching
(square), or perivascular distribution (rectangle). (D) There is no difference in the expression of Iba1 in Cx3CR1gfp/gfp DBA/2J retinas (n.s., *: p > 0.05; Student’s
t-test; error bars represent the SEM, 5 retinas per condition). (E–G): Distribution of the number of branched (E), perivascular (F), and amoeboid shaped Iba1+ cells
(G) within the central retina in DBA/2J (blue, n = 31) and Cx3cr1gfp/gfp DBA/2J (red n = 36) sorted in ascending order. There are significantly more amoeboid Iba1+
cells (1.7-fold *p < 0.05; Wilcoxon ranked sum test) in Cx3cr1gfp/gfp retinas. There are no statistically significant changes in the numbers of branched or perivascular
Iba1+ cells (n.s. p > 0.05; Student’s t-test and Wilcoxon ranked sum test respectively). Horizontal lines indicate the population mean, dashed lines indicate 1
standard deviation above and below the mean. Error bars represent the SEM. Scale bars: 500 µm (A), 250 µm (B), 50 µm (C).
cell activation. We also assessed changes in expression of the
proinflammatory gene Il1β in Cx3cr1gfp/gfp DBA/2J and DBA/2J
retinas by qRT-PCR and found a 2.34-fold increase, but this
was not significant (n = 6 each genotype; p = 0.1 by Student’s
t-test, data not shown). Since loss of Cx3cr1 has been shown to
increase expression of Il1β [26, 57] we performed qRT-PCR on
FACS-sorted CD11b+ CD45+ cells (Figures 6E–G). In contrast
to whole retinamRNA levels, Il1βwas reduced by 33% inmyeloid
cells from Cx3cr1gfp/gfp DBA/2J (n = 6) retinas vs. DBA/2J (n =
8) retinas, suggesting that this population is not contributing to
increased expression of this gene in the DBA/2J retina.
Since reactive nitric oxide (NO) from activated microglia
can induce axon transport deficits (Stagi et al., 2005), we
performed qRT-PCR analysis to assess changes in the expression
of Nos-2, which contributes to the production of NO. We
found a 1.89-fold increase in Nos-2 expression in Cx3cr1gfp/gfp
DBA/2J and DBA/2J whole retinas, which was not significant
(n = 6 each genotype; p = 0.1 by Student’s t-test, data not
shown), but when we enriched for myeloid cells by FACS-
sorting CD11b+ CD45+ cells (Figures 6D–F) we observed a
3-fold increase in Nos-2 in myeloid cells from Cx3cr1gfp/gfp
DBA/2J (n = 6) retinas vs. DBA/2J (n = 8) retinas (Figure 6I).
Thus, we find selective changes in the expression of genes
in myeloid cells consistent with a role in disrupting axon
transport.
DISCUSSION
Loss of Cx3cr1 Affects Compartmentalized
RGC Degeneration
We found that loss of Cx3cr1 in the DBA/2J model of chronic
glaucoma had a selective effect on somal accumulation of
pNF in RGCs in 10–11 month-old mice, suggesting deficits in
axonal transport. These effects were uncoupled from other RGC
degenerative changes, including loss of Brn3 gene transcription
or optic nerve histopathology. We also observed increased
infiltration of CCR2+ peripheral macrophages, but no change
in myeloid cell activation overall, since resident microglia
were not altered in density, or morphology, and overall levels
of Iba1 mRNA were unaffected. Our findings suggest that
distinct mechanisms may contribute to different aspects of RGC
decline in glaucoma, with axonal transport selectively altered
after loss of Cx3cr1 in myeloid cells such as microglia and
macrophages.
Loss of Cx3cr1 Enhances Axon Transport
Deficits in RGC Neurodegeneration
We observed that loss of Cx3cr1 resulted in enhanced somal
accumulation of pNF, as well as reduced expression of the
anterograde transport motor Kif1b, consistent with exacerbation
of axonal transport deficits. There is a correlate in humans
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FIGURE 6 | Amoeboid Iba1+ cells are peripherally derived
macrophages. (A) Amoeboid Iba1+ cells localize to the neurofibrillary layer.
Volume view of a DBA/2J retinal whole mount stained for the axonal marker
pNF (red) and the microglia/macrophage marker Iba1 (green). Orthogonal
views shown below and to the right. Amoeboid Iba1+ cells showed
(Continued)
FIGURE 6 | Continued
non-specific reactivity with the donkey anti-mouse secondary antibody used to
detect pNF (not shown). (B) Single z-plane (0.8 µm) from a control DBA/2J
retinal whole mount immunostained for the peripheral macrophage marker
Ccr2 (red) and Iba1 (white). The amoeboid shaped Iba1+ cells are positive for
Ccr2 (arrows) while branched Iba1+ cells are negative. (C) Single z-plane (0.8
µm) from a Cx3cr1gfp/gfp DBA/2J retina immunostained for the peripheral
macrophage marker Ccr2 (red) and Iba1 (white). As in (B) the amoeboid
shaped Iba1+ cells are positive for Ccr2 (arrows) while branched Iba1+ cells
are negative. (D) There is significantly more expression of Ccr2 and Ccl2 in
Cx3cr1gfp/gfp DBA/2J whole retina cDNA (3 and 2-fold more expression
respectively, *p < 0.05; Student’s t-test; error bars represent the SEM, 5
retinas per condition). (E) Gating parameters were set by dissociated retinal
cells not exposed to antibodies. 56,935 viable cells collected. (F) Left,
representative plot of DBA/2J assessing CD45+ CD11b+ (gate shown) from
129,000 to 200,000 viable cells. Right, histograms and percent CCR2+ of
gated CD45+CD11b+ population. (G) Left, representative plots of
Cx3cr1gfp/gfp DBA/2J assessing CD45+ CD11b+ (gate shown) from 129,000
to 200,000 viable cells as in F. Right, histograms and percent CCR2+ of gated
CD45+CD11b+ population. (H) Top, total number and percent of CCR2+ and
CCR2− of all CD45+CD11b+ cells analyzed by flow cytometry in DBA/2J n =
8 pooled retinas (293,780 cells collected). Bottom, total number and percent
of CCR2+ and CCR2− of all CD45+CD11b+ cells analyzed by flow cytometry
in Cx3cr1gfp/gfp DBA/2J n = 6 pooled retinas (453,727 cells collected). (I):
There is ∼3-fold more expression of Nos2 but 33% less expression of IL1β in
FACS sorted myeloid cells (n = 8 DBA/2J pooled retinas and n = 6
CX3CR1gfp/gfp DBA/2J pooled retinas). Scale bars: 50 µm (B,C) 10 µm (A).
where mutations in KIF1A affect axonal transport and can
lead to progressive neurodegeneration, including optic atrophy
(Okamoto et al., 2014). Decline in axonal transport is an early
and prevalent feature of many forms of neurodegeneration,
including glaucoma, generally preceding signs of structural
axon degeneration (Pease et al., 2000; Quigley et al., 2000; De
Vos et al., 2008; Soto et al., 2008; Crish et al., 2010, 2013;
Chidlow et al., 2011; Millecamps and Julien, 2013; Dengler-
Crish et al., 2014). Our findings are consistent with previous
studies showing that neuroinflammation, including microglia
activation and oxidative stress, is a contributing factor to early
axon transport dysfunction (Takeuchi et al., 2005). In an animal
model of multiple sclerosis, which is characterized by significant
neuroinflammation, axon transport deficits were found to be
an early state of axonal dysfunction. These deficits preceded
structural changes to axons and could be reversed by anti-
inflammatory as well as anti-oxidant treatment (Sorbara et al.,
2014).
We observed increased expression of Nos-2 in retinal
DBA/2J myeloid cells lacking Cx3cr1. Reactive nitric oxide
(NO) from microglia can focally induce axon transport
deficits in vitro (Stagi et al., 2005), and promote axonal
damage in vivo (Nikic et al., 2011). Nos-2 is not required
for RGC death and axon degeneration in DBA/2J mice
(Libby et al., 2007), but effects on axon transport have
not been assessed. Therefore, it is possible that there is a
selective role for this pathway in this aspect of neuronal
decline, consistent with our findings. Notably, alleviating
oxidative stress in the DBA/2J model with alpha-lipoic acid
treatment results in improved axonal transport (Inman et al.,
2013).
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Optic Nerve Degeneration and Brn3
Downregulation Are Not Affected by Loss
of Cx3cr1
While we observed an increase in somal accumulation of
pNF, there was no change in structural degeneration of the
optic nerve in Cx3cr1gfp/gfp DBA/2J mice relative to DBA/2J
mice. This may be due to the fact that structural decline of
axons can lag changes in transport, as shown in a model
of multiple sclerosis (Sorbara et al., 2014). Consistent with
this, there is structural persistence in the optic pathway
well after axon transport failure in an ocular hypertension
model of glaucoma (Crish et al., 2010; Crish and Calkins,
2011). Notably, in glaucoma patients, functional decline of
RGCs as measured by pattern electroretinography (PERG)
significantly precedes structural changes, such as loss of
nerve fiber layer thickness (Banitt et al., 2013), and in
animal models reduced PERG amplitude can result from
blockade of axon transport (Chou et al., 2013). Alternatively,
structural degeneration of axons may be independently
regulated, for example by calpain-dependent cleavage of
cytoskeletal components (Crish and Calkins, 2011; Wang et al.,
2012).
Interestingly, there are other instances of somal accumulation
of pNF in RGCs being uncoupled from optic nerve degeneration.
The wabbler-lethal mutant mouse has a loss of function mutation
in the phosphatidyl-serine flippase, Atp8a2 that is involved in
apoptosis and vesicle trafficking (Zhu et al., 2012; van der
Mark et al., 2013). This mutant mouse shows disrupted axonal
transport with an increase in RGCs with somal pNF, without
observed increased damage to the optic nerve (Zhu et al., 2012).
Since we found a significant reduction in expression of Atp8a2
in Cx3cr1gfp/gfp DBA/2J vs. DBA/2J retinas, it is possible that
loss of this pathway may be in part responsible for mediating
the reduced RGC axonal transport phenotype. These results raise
the question of whether exoplasmic-facing phosphatidyl-serine
signaling to receptors on microglia or macrophages affects RGC
degeneration, or if a cell autonomous role in membrane fluidity
affects axonal transport.
In our study, Brn3 downregulation was also similar in both
Cx3cr1gfp/gfp DBA/2J and DBA/2J retinas. This suggests the
density of RGCs was not significantly different with loss of
Cx3cr1, and that Cx3cr1 signaling does not influence this
early aspect of RGC degeneration. Thus, different aspects of
RGC decline may occur at different rates or be regulated
by distinct mechanisms. Consistent with this, deficiency in
the dual leucine kinase (Dlk) signaling pathway alters somal
but not axonal RGC degeneration (Fernandes et al., 2014).
In contrast to our findings, significant reductions in beta
tubulin III labeled RGCs were observed in a transient ocular
hypertension model of glaucoma in Cx3cr1gfp/gfp C57Bl6/J mice
(Wang et al., 2014). Thus, it is possible that Cx3cr1 signaling
has different effects in an acute injury vs. chronic model of
RGC degeneration. Overall, our findings suggest that loss of
fractalkine signaling selectively affects axon transport, providing
evidence that distinct pathways mediate specific aspects of
compartmentalized neurodegeneration.
Loss of Cx3cr1 Does Not Alter Microglial
Activation
FKN signaling has been found to be a brake on microglial
activation in many models of neurodegeneration (Cardona et al.,
2006; Wolf et al., 2013; Limatola and Ransohoff, 2014). However,
we found that the activation of the presumed resident microglia
(branched, parenchymal Iba1+ cells) remained unchanged in
terms of morphology and Iba1 mRNA levels with loss of Cx3cr1.
A similar lack of change in microglia activation in Cx3cr1
knockouts was also observed in other disease models, such as
prion-infected mice (Striebel et al., 2016). Activated microglia
can secrete pro-inflammatory cytokines like Il1β (Patterson,
2015), and loss of Cx3cr1 has been shown to elevate levels
of the pro-inflammatory cytokine Il1β (Cardona et al., 2006)
In diabetic retinopathy, only a few genes associated with
inflammation are significantly upregulated in Cx3cr1 knockout
retina, including Il1β (Cardona et al., 2015). However, while
we found that Nos2 was upregulated, as discussed above,
we did not observe a significant increase in Il1β with loss
of Cx3cr1 in the DBA/2J retina or in sorted myeloid cells
including microglia. Thus, we conclude that overall levels of
myeloid cell activation were not altered by loss of Cx3cr1
in this model, but that specific genes and pathways may be
affected.
Other aspects of microglia function may also be affected by
loss of Cx3cr1. For example, Cx3cr1 null microglia have been
noted to more slowly remodel their processes (Liang et al.,
2009), suggesting functional impairment. Whether this occurs
in our model remains unclear. We also observed a perivascular
population of Iba1+ cells that frequently lined up along axons
(Figure 6A) in a manner reminiscent of that seen by CD11c+
dendritic cells in the optic nerve crush model of axonal injury
(Lehmann et al., 2010; Heuss et al., 2014). Whether these cells
represent a second niche of dendritic cells in the retina (Heuss
et al., 2014) or a subpopulation of microglia (Dando et al.,
2016) is unclear, but the proximity to RGC axons and retinal
vessels suggest these cells would be a fruitful target in glaucoma
research.
Loss of Cx3cr1 Promotes Enhanced
Macrophage Infiltration
While we did not observe obvious changes in microglia
activation, loss of Cx3cr1 clearly resulted in enhanced Ccr2+
monocyte/macrophage infiltration. Consistent with this, we also
found increased levels of expression of the ligand for Ccr2, Ccl2,
which can promote infiltration (Sennlaub et al., 2013). Ccl2
was also found to be increased in brains from prion-infected
Cx3cr1 knockout vs. wild type C57Bl6/J mice (Striebel et al.,
2016). Increased CCR2+ macrophage infiltration on a Cx3cr1
null background is consistent with what has been observed in age
and light damage models of subretinal inflammation that clearly
showed a pathogenic role for these infiltrating macrophages
(Sennlaub et al., 2013). However, since macrophages have been
implicated in RGC regeneration (Cui et al., 2009; Yin et al.,
2009), it is unclear whether their role in RGC compartmentalized
degeneration is beneficial or detrimental. However, the increase
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in Ccr2+ macrophages in Cx3cr1gfp/gfp DBA/2J retinas makes
them a candidate for impacting axonal transport in RGCs
since the numbers of resident microglia and perivascular
macrophages were unchanged between the genotypes. Since
differences do exist between the DBA/2J and acute models of
IOP elevation, such as microbead injection (Sappington et al.,
2010) or injection of hypertonic saline into episcleral veins
(Morrison et al., 2011; Johnson et al., 2014) it may prove fruitful
to evaluate the role of microglia and macrophages in these
models.
Overall, our findings indicate that loss of Cx3cr1 increased
the infiltration of CCR2+ macrophages into the DBA/2J retina,
and selectively increased axonal transport dysfunction in this
mouse model of chronic glaucoma, potentially driven by
increased Nos2 expression in Cx3cr1-null myeloid cells. Thus,
alterations in myeloid function may contribute to the impaired
axonal transport seen early in many neurodegenerative diseases
(Millecamps and Julien, 2013).
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